Types of superdisintegrants, mechanisms and applications in pharmaceutical formulation

1. General introduction to superdisintegrants

Superdisintegrants are essential components required in solid dosage forms, serving the following primary roles:

• Improving tablet disintegration: Facilitating the breakdown of the tablet matrix upon contact with gastrointestinal fluids.
• Enhancing the solubility, dissolution rate, and bioavailability of the active ingredient: Particularly crucial for poorly soluble active pharmaceutical ingredients (APIs).

To effectively fulfill their functions, superdisintegrants should possess the following properties, depending on the dosage form, the API, and the specific manufacturing process utilized:

• Rapid disintegration action at low usage concentrations.
• Good flowability (specifically for tablets manufactured via direct compression).
• High compressibility, enabling the production of tablets with high hardness and low friability.
• Excellent wetting properties.
• No chemical incompatibility with ionic substances (in cases where the API or other excipients in the formulation are in an ionic state).
• No interference with the drug release profile (applicable to modified-release dosage forms).
• Consistent water absorption and swelling capabilities regardless of changes in environmental pH.

2. Disintegration mechanisms of superdisintegrants

Typically, superdisintegrants operate primarily through three mechanisms: swelling, wicking, and shape recovery.

Most current superdisintegrants function through a combination of the aforementioned mechanisms to varying extents.

Sodium Starch Glycolate (Cross-linked sodium carboxymethyl starch)

• Exhibits robust swelling properties, especially in grades derived from potato starch (swelling up to 200 times its original volume).
• Highly suitable for poorly soluble active pharmaceutical ingredients (APIs).
• Swells to form a gel; therefore, usage levels exceeding 8% in the formulation risk hindering tablet disintegration and drug release profiles.
• Recommended usage level: 2% – 8%.Croscarmellose Sodium: Cross-linked sodium carmellose
• Operates through a dual mechanism of swelling and wicking.
• Suitable for formulations containing either water-soluble or insoluble components.
• A widely utilized superdisintegrant. Recommended usage level: 1% – 4%.

Crospovidone (PVPP) (Cross-linked derivative of N-vinylpyrrolidone)

• Facilitates tablet disintegration via all three primary mechanisms: swelling, wicking, and shape recovery.
• A non-ionic superdisintegrant, ensuring no chemical incompatibility with ionic APIs.
• Does not form a gel, even at high concentrations of up to 10%.
• Water absorption and swelling capabilities remain unaffected by changes in environmental pH.
• Recommended usage level: 1% – 4%.
• Available in two distinct particle-size grades, XL and XL-10, to accommodate various formulation requirements.

Crospovidone (PVPP) (a derivative of N-vinylpyrrolidone)

• Functions through all three disintegration mechanisms: swelling, wicking, and deformation recovery
• A non-ionic superdisintegrant that does not cause incompatibility with ionic active pharmaceutical ingredients (APIs)
• Does not form a gel even at high concentrations up to 10%
• Water uptake and swelling capacity remain stable across different pH conditions
• Recommended usage level: 1–4%
• Available in two grades with different particle sizes: XL and XL-10, suitable for various applications

Polacrilin Potassium

• Facilitates tablet disintegration via all three mechanisms: swelling, wicking, and shape recovery.
• Features a high swelling capacity without gel formation.
• A non-ionic superdisintegrant, preventing incompatibilities with ionic APIs.